SNNC · Sibannac, Inc. · Metrics
Market Cap
$82,378
Shares
17.53M
Volume · Nov 11
114K
Avg daily vol (3M)
396.32K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
SNNC metrics
45 of 125 screener metrics currently available.
Market overview
2 metricsShare price
$0.00
Market cap
$82,378
Price action
23 metricsPrice change (1W)
+6.8%
Price change (30D)
+6.8%
Price change (3M)
-47.8%
Price change (6M)
-64.9%
Price change (YTD)
-62.1%
Price change (1Y)
-66.4%
Trailing year
Price change (5Y)
-96.4%
52-week high
$0.02
52-week low
$0.00
Change from 52-week high
-78.6%
Change from 52-week low
+38.2%
Annualized volatility
347.0%
Annualized volatility (3M)
—
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
-1.4
RSI (14D)
50.2
Price vs SMA 50
-2.5%
Price vs SMA 200
-45.3%
Avg volume (3M)
396,321
Relative volume
0.3
Average dollar volume
$2,137
Company
3 metricsSector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
17.53M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-320.2%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
−$62,365
Operating profit (TTM)
−$106,831
Net income (TTM)
−$263,756
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-99.9%
Year over year
Net income growth YoY
—
Revenue (TTM)
−$213,447
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.0%
Year over year
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
-100.5%
Debt / equity
—
Current ratio
0.0
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
-2.9
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$116,522
Total assets
$262,340
Total debt
$287,471
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$41,547
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
9 metrics13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
—
Holder tenure
—
Price vs estimated holder cost
—
Ownership (registered funds)
1 metricsIndex-fund ownership
0.0%
Short interest
3 metricsShort interest
—
Latest settlement
Days to cover
—
Short-squeeze score
—
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—